SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Eva Perón Synthetic CCD — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientEva Perón
Date of birth1919-05-07
IdentifiersMRN HR-ML025-SYN-TD; SSN (made up) 000-25-7316
Document date2026-11-01
AuthorLucía Barragán, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

New patient with four months of bleeding after intercourse and between periods and tiredness: history in Spanish, speculum examination, a visible cervical mass biopsied, HPV test and cytology, anemia tests, and her wishes about how results are given. Concerns: She has bled after intercourse and between periods for months and is exhausted, and she wants to know the cause; Whatever the results show, she wants to be told the truth herself, in Spanish, before anyone else is told; She wants to keep working and to understand how any treatment would affect her body and her chance of having children. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth once daily, with vitamin C-rich food or juice, apart from tea and dairyOne tablet by mouth once dailyOral route1951-02-09 to 1951-08-17completedS
Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours when needed for pelvic pain, no more than 6 tablets a dayOne or two tablets every 6 hours when needed, no more than 6 a dayOral route1951-02-09activeS
Nitrofurantoin (monohydrate and macrocrystals) 100 mg oral capsule, one capsule by mouth twice daily with food for 5 daysOne capsule twice daily with food for 5 daysOral route1951-03-27 to 1951-03-31completedS
Cisplatin 40 mg/m2 (64 mg) intravenous infusion once weekly for five weeks during pelvic radiation, with hydration and antiemetic premedication in the infusion center64 mg intravenously once weekly for five dosesIntravenous route1951-03-09 to 1951-04-06completedS
Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours when needed for nausea in the days after cisplatinOne tablet every 8 hours when needed for nauseaOral route1951-03-09 to 1951-04-10completedS
Loperamide 2 mg oral capsule, two capsules after the first loose stool, then one after each loose stool, no more than 8 a dayTwo capsules after the first loose stool, then one after each, no more than 8 a dayOral route1951-03-09 to 1951-05-04completedS
Estradiol 0.1 mg per day transdermal patch, one patch changed twice weeklyOne patch changed twice weeklyTopical route1951-05-18activeS
Progesterone 100 mg oral capsule, one capsule by mouth nightly, to protect any remaining endometrium while on estradiolOne capsule by mouth nightlyOral route1951-05-18activeS

Procedures

ProcedureDatesStatusEvidence
Punch biopsy of a visible cervical mass at the first visit, with an HPV test and cytology1951-02-09 to 1951-02-09completedS
Advance care planning conversation, about 18 minutes, in Spanish1951-09-21 to 1951-09-21completedS
Colposcopy of the cervix and vagina, with pelvic and rectovaginal examination, at the gynecologic oncology consultation1951-02-17 to 1951-02-17completedS
Pelvic MRI with contrast for staging1951-02-23 to 1951-02-23completedS
FDG PET-CT from the skull base to mid-thigh for staging1951-02-25 to 1951-02-25completedS
Pelvic external beam radiation therapy, 45 Gy in 25 fractions by intensity-modulated radiation therapy, with weekly cisplatin1951-03-09 to 1951-04-10completedS
Image-guided high-dose-rate intracavitary brachytherapy, 28 Gy in 4 weekly fractions1951-04-13 to 1951-05-04completedS
FDG PET-CT three months after treatment to assess response1951-08-10 to 1951-08-10completedS

Immunizations

DateVaccineStatusEvidence
1951-09-21Influenza vaccine, 1951-1952 seasoncompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
January 1950Fainting followed by an appendectomyD (CLM-0003)
1950Persistent weakness and anemia from vaginal bleeding after the appendectomy, with further tests delayedD (CLM-0003)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
She has bled after intercourse and between periods for months and is exhausted, and she wants to know the causeactiveS
Whatever the results show, she wants to be told the truth herself, in Spanish, before anyone else is toldactiveS
She wants to keep working and to understand how any treatment would affect her body and her chance of having childrenactiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 10.4 on 1951-03-27; MCV [Entitic mean volume] in Red Blood Cells by Automated count 77 on 1951-03-02; Leukocytes [#/volume] in Blood by Automated count 4.1 on 1951-03-27; Platelets [#/volume] in Blood by Automated count 168 on 1951-03-27; Ferritin [Mass/volume] in Serum or Plasma 48 on 1951-08-17; Pain severity - 0-10 verbal numeric rating [Score] - Reported 0 on 1951-08-17; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1951-09-21; Creatinine [Mass/volume] in Serum or Plasma 0.8 on 1951-03-27; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1946)/1.73 sq M 101 on 1951-03-27; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 on 1951-08-17; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 4 on 1951-08-17; Neutrophils [#/volume] in Blood by Automated count 2.6 on 1951-03-27; Total score [AUDIT-C] 1 on 1951-09-21; Follitropin [Units/volume] in Serum or Plasma 72 on 1951-05-18; Estradiol (E2) [Mass/volume] in Serum or Plasma 14 on 1951-05-18; Magnesium [Mass/volume] in Serum or Plasma 1.9 on 1951-05-18 [S]

Strengths and supports: Supports: a close friend and a long-time colleague at the foundation; her work gives her purpose. She would like the hospital's spiritual care team offered when she is in treatment [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Bleeding after intercourse and between periods, with heavier periods, for about four months, with tiredness and a dull pelvic ache. Never had cervical screening. Speculum examination shows a friable, exophytic mass about 4 cm across on the cervix that bleeds on contact. Punch biopsy, HPV test and cytology taken; urgent gynecologic oncology consultation bookedresolvedconfirmed N93.8S — Synthetic presenting problem linked to her documented abnormal bleeding with anemia; superseded by the diagnosis at the consultation.
Iron deficiency anemia from chronic blood loss: hemoglobin 9.4 g/dL, mean cell volume 72 fL, ferritin 6 ng/mL, with tiredness and breathlessness on stairsresolvedconfirmed D50.0S — Synthetic modern finding linked to her documented anemia from vaginal bleeding.
Invasive squamous cell carcinoma of the cervix, HPV 16 positive: an exophytic tumor about 4.5 cm across with clinical involvement of the left parametrium, not reaching the pelvic wall; pelvic MRI and PET-CT ordered for FIGO 1943 staging. Synthetic modern episode linked to her documented cervical canceractiveconfirmed C53.9S — Synthetic modern diagnosis made at the gynecologic oncology consultation.
Acute cystitis during pelvic chemoradiation: two days of new burning, urgency and cloudy urine on top of mild radiation frequency, without fever or flank pain; urine dipstick positive for leukocyte esterase and nitrite; culture grew Escherichia coli sensitive to nitrofurantoin; neutrophil count and kidney function normal; resolvedresolvedconfirmed N30.00S — Synthetic acute infection; not a historical claim.
Ovarian failure after pelvic radiation, with hot flashes, night sweats, poor sleep and vaginal dryness two weeks after treatment; FSH 72 mIU/mL and estradiol 14 pg/mLactiveconfirmed E89.41S — Synthetic expected effect of pelvic chemoradiation.

Results

DateMeasureValueUnitReference rangeFlagProvenance
1951-02-09Hemoglobin [Mass/volume] in Blood9.4g/dL11.6-15 g/dLLowS
1951-02-09MCV [Entitic mean volume] in Red Blood Cells by Automated count72fL80-100 fLLowS
1951-02-09Leukocytes [#/volume] in Blood by Automated count7.110*3/uL4-11 10*3/uLNormalS
1951-02-09Platelets [#/volume] in Blood by Automated count39810*3/uL150-400 10*3/uLNormalS
1951-02-09Ferritin [Mass/volume] in Serum or Plasma6ng/mLA ferritin of 30 ng/mL or less indicates iron deficiencyLowS
1951-02-09Pain severity - 0-10 verbal numeric rating [Score] - Reported4{score}S
1951-02-09Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
1951-02-17Creatinine [Mass/volume] in Serum or Plasma0.7mg/dL0.5-1.1 mg/dLNormalS
1951-02-17Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1946)/1.73 sq M117mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1951-02-17Pain severity - 0-10 verbal numeric rating [Score] - Reported4{score}S
1951-02-17Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]9{score}S
1951-02-17Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]9{score}S
1951-03-02Hemoglobin [Mass/volume] in Blood10.2g/dL11.6-15 g/dLLowS
1951-03-02MCV [Entitic mean volume] in Red Blood Cells by Automated count77fL80-100 fLLowS
1951-03-02Leukocytes [#/volume] in Blood by Automated count6.810*3/uL4-11 10*3/uLNormalS
1951-03-02Platelets [#/volume] in Blood by Automated count35210*3/uL150-400 10*3/uLNormalS
1951-03-02Pain severity - 0-10 verbal numeric rating [Score] - Reported3{score}S
1951-03-02Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]8{score}S
1951-03-02Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]7{score}S
1951-05-18Hemoglobin [Mass/volume] in Blood11.2g/dL11.6-15 g/dLLowS
1951-05-18Creatinine [Mass/volume] in Serum or Plasma0.8mg/dL0.5-1.1 mg/dLNormalS
1951-05-18Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1946)/1.73 sq M101mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1951-05-18Pain severity - 0-10 verbal numeric rating [Score] - Reported1{score}S
1951-05-18Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]7{score}S
1951-05-18Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]6{score}S
1951-08-17Hemoglobin [Mass/volume] in Blood12.6g/dL11.6-15 g/dLNormalS
1951-08-17Ferritin [Mass/volume] in Serum or Plasma48ng/mLA ferritin of 30 ng/mL or less indicates iron deficiencyNormalS
1951-08-17Pain severity - 0-10 verbal numeric rating [Score] - Reported0{score}S
1951-08-17Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
1951-08-17Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]4{score}S
1951-03-27Leukocytes [#/volume] in Blood by Automated count4.110*3/uL4-11 10*3/uLNormalS
1951-03-27Neutrophils [#/volume] in Blood by Automated count2.610*3/uL1.5-7.5 10*3/uLNormalS
1951-03-27Hemoglobin [Mass/volume] in Blood10.4g/dL11.6-15 g/dLLowS
1951-03-27Platelets [#/volume] in Blood by Automated count16810*3/uL150-400 10*3/uLNormalS
1951-03-27Creatinine [Mass/volume] in Serum or Plasma0.8mg/dL0.5-1.1 mg/dLNormalS
1951-03-27Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1946)/1.73 sq M101mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1951-09-21Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1951-09-21Total score [AUDIT-C]1{score}S
1951-05-18Follitropin [Units/volume] in Serum or Plasma72m[IU]/mLTypical premenopausal follicular-phase rangeHighS
1951-05-18Estradiol (E2) [Mass/volume] in Serum or Plasma14pg/mLTypical premenopausal rangeLowS
1951-05-18Magnesium [Mass/volume] in Serum or Plasma1.9mg/dL1.7-2.4 mg/dLNormalS

Social History

Vital Signs

DateMeasureValueUnitProvenance
1951-02-09Body height165cmS
1951-02-09Body weight53kgS
1951-02-09Body mass index (BMI) [Ratio]19.5kg/m2S
1951-02-09Systolic blood pressure108mm[Hg]S
1951-02-09Diastolic blood pressure68mm[Hg]S
1951-02-09Heart rate92/minS
1951-02-09Respiratory rate16/minS
1951-02-09Body temperature36.8CelS
1951-02-09Oxygen saturation in Arterial blood by Pulse oximetry99%S
1951-02-17Body height165cmS
1951-02-17Body weight52.8kgS
1951-02-17Body mass index (BMI) [Ratio]19.4kg/m2S
1951-02-17Systolic blood pressure112mm[Hg]S
1951-02-17Diastolic blood pressure70mm[Hg]S
1951-02-17Heart rate90/minS
1951-02-17Respiratory rate16/minS
1951-02-17Body temperature36.7CelS
1951-02-17Oxygen saturation in Arterial blood by Pulse oximetry99%S
1951-03-02Body height165cmS
1951-03-02Body weight52.5kgS
1951-03-02Body mass index (BMI) [Ratio]19.3kg/m2S
1951-03-02Systolic blood pressure110mm[Hg]S
1951-03-02Diastolic blood pressure68mm[Hg]S
1951-03-02Heart rate84/minS
1951-03-02Respiratory rate14/minS
1951-03-02Body temperature36.7CelS
1951-03-02Oxygen saturation in Arterial blood by Pulse oximetry99%S
1951-05-18Body height165cmS
1951-05-18Body weight50.6kgS
1951-05-18Body mass index (BMI) [Ratio]18.6kg/m2S
1951-05-18Systolic blood pressure104mm[Hg]S
1951-05-18Diastolic blood pressure66mm[Hg]S
1951-05-18Heart rate80/minS
1951-05-18Respiratory rate14/minS
1951-05-18Body temperature36.6CelS
1951-05-18Oxygen saturation in Arterial blood by Pulse oximetry99%S
1951-08-17Body height165cmS
1951-08-17Body weight52.4kgS
1951-08-17Body mass index (BMI) [Ratio]19.2kg/m2S
1951-08-17Systolic blood pressure108mm[Hg]S
1951-08-17Diastolic blood pressure68mm[Hg]S
1951-08-17Heart rate74/minS
1951-08-17Respiratory rate14/minS
1951-08-17Body temperature36.6CelS
1951-08-17Oxygen saturation in Arterial blood by Pulse oximetry99%S
1951-03-27Body height165cmS
1951-03-27Body weight51.4kgS
1951-03-27Body mass index (BMI) [Ratio]18.9kg/m2S
1951-03-27Systolic blood pressure106mm[Hg]S
1951-03-27Diastolic blood pressure66mm[Hg]S
1951-03-27Heart rate88/minS
1951-03-27Respiratory rate16/minS
1951-03-27Body temperature37.2CelS
1951-03-27Oxygen saturation in Arterial blood by Pulse oximetry99%S
1951-09-21Body height165cmS
1951-09-21Body weight52.8kgS
1951-09-21Body mass index (BMI) [Ratio]19.4kg/m2S
1951-09-21Systolic blood pressure110mm[Hg]S
1951-09-21Diastolic blood pressure70mm[Hg]S
1951-09-21Heart rate72/minS
1951-09-21Respiratory rate14/minS
1951-09-21Body temperature36.6CelS
1951-09-21Oxygen saturation in Arterial blood by Pulse oximetry99%S

Encounters

DatePurposeStatusProvenance
1951-02-09New patient with four months of bleeding after intercourse and between periods and tiredness: history in Spanish, speculum examination, a visible cervical mass biopsied, HPV test and cytology, anemia tests, and her wishes about how results are givenfinishedS
1951-02-17Biopsy result given to her in person, and gynecologic oncology consultation the same day: diagnosis, staging plan, treatment options, and fertility and ovarian function counselingfinishedS
1951-03-02Staging results (pelvic MRI and PET-CT), FIGO stage, and her treatment and fertility decisions before chemoradiationfinishedS
1951-03-27Same-day sick visit for burning on passing urine during chemoradiationfinishedS
1951-05-18Review two weeks after completing chemoradiation and brachytherapy: side effects, menopause symptoms, and survivorship carefinishedS
1951-08-17Review three months after treatment: PET-CT response, examination, anemia, mood, and the follow-up planfinishedS
1951-09-21Periodic adult preventive visit after cancer treatmentfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Diagnosis of a visible cervical lesion: punch biopsy at this visit, an HPV test and cytology, a pregnancy test, a blood count and ferritin; a lesion that looks like cancer is biopsied directly rather than managed by the screening algorithmcompletedGL-ASCCP-2019, GL-NCCN-CERV-2027S
Urgent gynecologic oncology consultation, on the day the biopsy result is given: diagnosis, staging, treatment by stage, and fertility and ovarian function counselingcompletedGL-NCCN-CERV-2027, GL-ASCO-FP-2018S
Truthful disclosure as she asked: the biopsy result given to her in person, in Spanish, at a visit with time set aside, before anyone else is told; she chooses who is present and who is told; a professional medical interpreter for clinicians who do not speak Spanish, never a family member; information shared step by step, checking what she wants to knowcompletedGL-ASCO-COMM-2017S
Iron deficiency anemia: ferrous sulfate daily, a blood count at about one month, a ferritin at the end of the course, and acetaminophen rather than anti-inflammatory painkillers for pelvic paincompletedGL-CMID-2026S
FIGO 1943 staging: pelvic MRI and FDG PET-CT, kidney function before cisplatin, an HIV test, and an examination of the vagina and parametriacompletedGL-FIGO-2018, GL-NCCN-CERV-2027S
Fertility and ovarian function counseling before treatment: chemoradiation ends the ability to carry a pregnancy and usually ends ovarian function; egg or embryo freezing (about two weeks), surgical moving of the ovaries out of the radiation field, and a gestational carrier were explained; her decision is recordedcompletedGL-ASCO-FP-2018, GL-NCCN-CERV-2027S
Psychosocial support: the oncology social worker, the PHQ-9 and GAD-7 at diagnosis, before treatment, at the end of treatment and in follow-up, spiritual care when she asks, and help planning work around treatmentcompletedGL-ASCO-ANXDEP-2023, GL-ASCO-COMM-2017S
Definitive chemoradiation for stage IIB disease: pelvic external beam radiation 45 Gy in 25 fractions with weekly cisplatin 40 mg/m2, then image-guided high-dose-rate brachytherapy, all within eight weeks; weekly blood count, creatinine and magnesium; ondansetron for nausea and loperamide for diarrheacompletedGL-NCCN-CERV-2027, GL-FIGO-2018S
Survivorship care: a vaginal dilator three times a week, estradiol with progesterone for radiation-induced menopause until the usual age of menopause, gynecologic oncology review every three months for two years, PET-CT about three months after treatment, and warning symptoms to reportcompletedGL-NCCN-CERV-2027S

Goals

GoalTargetStatusOutcomeProvenance
Diagnosis and stage explained to her directly, in Spanish, with time for questions, before any treatment decision1951-03-02completedDiagnosis given to her in person at the second visit and the stage at the third; she made the treatment and fertility decisions herselfS
Hemoglobin 10 g/dL or more before radiation begins1951-03-02completedHemoglobin 10.2 g/dLS
Chemoradiation and brachytherapy completed within eight weeks1951-05-18completedCompleted in eight weeks, with five cisplatin dosesS
No evidence of disease on PET-CT and examination three months after treatment1951-08-17completedComplete metabolic response; examination without tumorS
PHQ-9 below 5 by six months1951-08-17completedPHQ-9 4S

Functional Status

Mental Status